3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lung Neoplasms
4
Squamous Cell Carcinoma of Head and Neck
3
Carcinoma, Non-Small-Cell Lung
3
Head and Neck Neoplasms
2
Tongue Neoplasms
1
Small Cell Lung Carcinoma
1
Recurrent Head and Neck Carcinoma
1
Precancerous Conditions
1
Pleural Effusion, Malignant
1
Neoplasm Metastasis
1
Mouth Neoplasms
1
Lymphoid Interstitial Pneumonia
1
Leukoplakia, Oral
1
Laryngeal Neoplasms
1
Barrett Esophagus
1
Interventions
Temozolomide
29
Bevacizumab
15
Radiotherapy
13
antineoplaston AS 2-1
8
antineoplaston A10
8
Everolimus
7
Radiation
6
Erlotinib Hydrochloride
6
Radiotherapy, Intensity-Modulated
5
Lomustine
4
veliparib
3
palbociclib
3
Vorinostat
3
Sunitinib
3
Radiotherapy, Conformal
3
Magnetic Resonance Spectroscopy
3
Carmustine
3
Carboplatin
3
temsirolimus
2
selinexor
2
poly ICLC
2
etoposide phosphate
2
cabozantinib
2
Sirolimus
2
Nivolumab
2
Irinotecan
2
Immunoglobulin G
2
Imatinib Mesylate
2
Etoposide
2
Donepezil
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Astrocytoma
×
Dihematoporphyrin Ether
×
Clear all
No trials found.